{"id":3764,"date":"2022-08-02T09:30:47","date_gmt":"2022-08-02T01:30:47","guid":{"rendered":"https:\/\/regask.com\/?p=3764"},"modified":"2024-10-25T00:45:40","modified_gmt":"2024-10-24T16:45:40","slug":"prioridades-de-cumplimiento-de-australia-para-2022","status":"publish","type":"post","link":"https:\/\/regask.com\/es\/australia-compliance-priorities-2022\/","title":{"rendered":"Australia: Procedimientos de cumplimiento de las normas de importaci\u00f3n, publicidad y suministro"},"content":{"rendered":"

El TGA<\/a> ha publicado una lista de prioridades de cumplimiento de importaci\u00f3n, publicidad y suministro desde el 1 de julio de 2022 hasta el 30 de junio de 2023:<\/p>\n

    \n
  1. Disuadir y abordar la importaci\u00f3n, publicidad y suministro ilegales de productos terap\u00e9uticos no aprobados asociados con COVID-19.<\/strong><\/li>\n
  2. Interrumpir y abordar la importaci\u00f3n, publicidad y suministro ilegales de productos de vapeo de nicotina.<\/strong><\/li>\n
  3. Garantizar el cumplimiento de los requisitos de la Ley de Productos Terap\u00e9uticos de 1989 en todo el\u00a0Industria del cannabis medicinal<\/strong><\/li>\n
  4. Interrumpir y abordar la importaci\u00f3n, fabricaci\u00f3n, publicidad y suministro ilegales de Productos terap\u00e9uticos no aprobados para mejorar el rendimiento y la imagen, incluidos los suplementos deportivos, <\/strong>con especial atenci\u00f3n a los productos que contienen venenos de las listas 4 y 8.<\/li>\n
  5. Disuadir y abordar la importaci\u00f3n, publicidad y suministro ilegales de Productos terap\u00e9uticos no aprobados utilizados en la industria de la belleza y la cosm\u00e9tica dental.<\/strong><\/li>\n
  6. Abordar el\u00a0Uso il\u00edcito de representaciones restringidas y prohibidas\u00a0<\/strong>en anuncios que no han sido aprobados o permitidos, en particular aquellos que se dirigen a consumidores especialmente vulnerables<\/li>\n
  7. Disuadir y abordar la publicidad il\u00edcita de\u00a0productos terap\u00e9uticos no aprobados en plataformas de comercio electr\u00f3nico;\u00a0<\/strong>Incluyendo productos para el embarazo y prenatales, productos para bajar de peso y curas para la resaca.<\/li>\n<\/ol>\n
    \n
    \n
    \n
    \n

    En relaci\u00f3n con el punto 4, la TGA propone centrarse en la importaci\u00f3n, fabricaci\u00f3n, publicidad, preparaci\u00f3n y suministro de productos no aprobados. Esto ir\u00e1 acompa\u00f1ado de educaci\u00f3n del consumidor y de una campa\u00f1a dirigida a las plataformas en l\u00ednea que publicitan suplementos deportivos no aprobados.<\/p>\n

    En relaci\u00f3n con el punto 6, la TGA se centrar\u00e1 en los anuncios il\u00edcitos relacionados con enfermedades o afecciones graves en las que el patrocinador no posee pruebas adecuadas para la indicaci\u00f3n y no ha ingresado la indicaci\u00f3n en el sitio.\u00a0Australia<\/span>n Registro de Productos Terap\u00e9uticos.<\/p>\n

    En relaci\u00f3n con el punto 7, la TGA ha identificado medicamentos complementarios no aprobados que se anuncian y venden a trav\u00e9s de plataformas en l\u00ednea y aquellos que incluyen testimonios ilegales e indicaciones no fundamentadas. Las actividades de cumplimiento incluir\u00e1n el control de productos terap\u00e9uticos no aprobados, productos terap\u00e9uticos aprobados con indicaciones y afirmaciones no aprobadas y testimonios ilegales que no cumplan con el C\u00f3digo de Publicidad de Productos Terap\u00e9uticos. Las \u00e1reas de enfoque son el embarazo, la atenci\u00f3n prenatal, la p\u00e9rdida de peso y las curas para la resaca.<\/p>\n

    Es posible que surjan otras \u00e1reas prioritarias de cumplimiento durante el a\u00f1o y se agreguen a la lista. Estas prioridades se suman a los programas de cumplimiento habituales de la TGA para las listas de medicamentos complementarios (revisiones posteriores a la comercializaci\u00f3n), el control y la vigilancia de las inclusiones de dispositivos m\u00e9dicos, los programas de farmacovigilancia e inspecci\u00f3n de buenas pr\u00e1cticas cl\u00ednicas y el programa de cumplimiento de las BPM.<\/p>\n

    \n
    \n
    \n
    \n
    \n
    \n
    \n
    \n
    \n
    \n
    \n

    Comun\u00edquese con RegASK para obtener m\u00e1s informaci\u00f3n sobre los cambios regulatorios de Australia.\u00a0<\/a><\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n\n\t\tContacte con RegASK para m\u00e1s detalles<\/span>\n\t<\/a>\n\n\n\t\tLeer m\u00e1s<\/span>\n\t<\/a>\n\n

    \n\n\t
    \n\t\t\t\t
    \n\t\t\t\n\t\t\t\n\n\t\tLea estudios de casos de la industria farmac\u00e9utica y biotecnol\u00f3gica<\/span>\n\t<\/a>\n\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\n\t\n<\/div>\n
    \n
    \n
    <\/div>\n<\/div>\n<\/div>","protected":false},"excerpt":{"rendered":"

    La TGA ha publicado una lista de prioridades de cumplimiento de importaci\u00f3n, publicidad y suministro desde el 1 de julio de 2022 hasta el 30 de junio de 2023: Disuadir y abordar la importaci\u00f3n, publicidad y suministro ilegales de productos terap\u00e9uticos no aprobados asociados con COVID-19. Interrumpir y abordar la importaci\u00f3n, publicidad y suministro ilegales de productos de vapeo de nicotina. Garantizar el cumplimiento de los requisitos\u2026<\/p>","protected":false},"author":39,"featured_media":2487,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[511,35],"tags":[40],"class_list":["post-3764","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-australia-regulations","category-pharma-biotech-latest-insights","tag-latest-insights"],"acf":[],"yoast_head":"\nAustralia: Import, Ads & Supply Compliance Priorities 2022 | RegASK<\/title>\n<meta name=\"description\" content=\"Australia's TGA has published a list of import, advertising and supply compliance priorities from I July 2022 to 30 June 2023.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/regask.com\/es\/prioridades-de-cumplimiento-de-australia-para-2022\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Australia: Import, Advertising and Supply Compliance Priorities 2022-23\" \/>\n<meta property=\"og:description\" content=\"Australia's TGA has published a list of import, advertising and supply compliance priorities from I July 2022 to 30 June 2023.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/regask.com\/es\/prioridades-de-cumplimiento-de-australia-para-2022\/\" \/>\n<meta property=\"og:site_name\" content=\"RegASK\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/RegASKRegulatoryAffairs\/\" \/>\n<meta property=\"article:published_time\" content=\"2022-08-02T01:30:47+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-10-24T16:45:40+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/regask.com\/wp-content\/uploads\/2021\/04\/pharma-pills.png\" \/>\n\t<meta property=\"og:image:width\" content=\"689\" \/>\n\t<meta property=\"og:image:height\" content=\"626\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Benoit Trouwaert\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@ASKRegASK\" \/>\n<meta name=\"twitter:site\" content=\"@ASKRegASK\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Benoit Trouwaert\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/regask.com\\\/australia-compliance-priorities-2022\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/regask.com\\\/australia-compliance-priorities-2022\\\/\"},\"author\":{\"name\":\"Benoit Trouwaert\",\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/person\\\/c1d261e8dcf7b1c30b2c4f2c119df42d\"},\"headline\":\"Australia: Import, Advertising and Supply Compliance Pr…\",\"datePublished\":\"2022-08-02T01:30:47+00:00\",\"dateModified\":\"2024-10-24T16:45:40+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/regask.com\\\/australia-compliance-priorities-2022\\\/\"},\"wordCount\":444,\"publisher\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/regask.com\\\/australia-compliance-priorities-2022\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2021\\\/04\\\/pharma-pills.png\",\"keywords\":[\"Latest Insights\"],\"articleSection\":[\"Australia\",\"Pharma and Biotech\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/regask.com\\\/australia-compliance-priorities-2022\\\/\",\"url\":\"https:\\\/\\\/regask.com\\\/australia-compliance-priorities-2022\\\/\",\"name\":\"Australia: Import, Ads & Supply Compliance Priorities 2022 | RegASK\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/regask.com\\\/australia-compliance-priorities-2022\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/regask.com\\\/australia-compliance-priorities-2022\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2021\\\/04\\\/pharma-pills.png\",\"datePublished\":\"2022-08-02T01:30:47+00:00\",\"dateModified\":\"2024-10-24T16:45:40+00:00\",\"description\":\"Australia's TGA has published a list of import, advertising and supply compliance priorities from I July 2022 to 30 June 2023.\",\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/regask.com\\\/australia-compliance-priorities-2022\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/regask.com\\\/australia-compliance-priorities-2022\\\/#primaryimage\",\"url\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2021\\\/04\\\/pharma-pills.png\",\"contentUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2021\\\/04\\\/pharma-pills.png\",\"width\":689,\"height\":626,\"caption\":\"Medication tablets\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/regask.com\\\/#website\",\"url\":\"https:\\\/\\\/regask.com\\\/\",\"name\":\"RegASK\",\"description\":\"Empowering Smarter Regulatory Decisions\",\"publisher\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/regask.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/regask.com\\\/#organization\",\"name\":\"RegASK\",\"url\":\"https:\\\/\\\/regask.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2024\\\/10\\\/RegASK-Logo-Dark-Round.png\",\"contentUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2024\\\/10\\\/RegASK-Logo-Dark-Round.png\",\"width\":401,\"height\":401,\"caption\":\"RegASK\"},\"image\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/RegASKRegulatoryAffairs\\\/\",\"https:\\\/\\\/x.com\\\/ASKRegASK\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/RegASK\\\/\",\"https:\\\/\\\/www.youtube.com\\\/playlist?list=PL6yPC6gFqelkHbOeyUVKjtHOZXZ2LQbJd\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/person\\\/c1d261e8dcf7b1c30b2c4f2c119df42d\",\"name\":\"Benoit Trouwaert\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Australia: prioridades de cumplimiento de las normas de importaci\u00f3n, publicidad y suministro para 2022 | RegASK","description":"La TGA de Australia ha publicado una lista de prioridades de cumplimiento en materia de importaci\u00f3n, publicidad y suministro desde el 1 de julio de 2022 hasta el 30 de junio de 2023.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/regask.com\/es\/prioridades-de-cumplimiento-de-australia-para-2022\/","og_locale":"es_ES","og_type":"article","og_title":"Australia: Import, Advertising and Supply Compliance Priorities 2022-23","og_description":"Australia's TGA has published a list of import, advertising and supply compliance priorities from I July 2022 to 30 June 2023.","og_url":"https:\/\/regask.com\/es\/prioridades-de-cumplimiento-de-australia-para-2022\/","og_site_name":"RegASK","article_publisher":"https:\/\/www.facebook.com\/RegASKRegulatoryAffairs\/","article_published_time":"2022-08-02T01:30:47+00:00","article_modified_time":"2024-10-24T16:45:40+00:00","og_image":[{"width":689,"height":626,"url":"https:\/\/regask.com\/wp-content\/uploads\/2021\/04\/pharma-pills.png","type":"image\/png"}],"author":"Benoit Trouwaert","twitter_card":"summary_large_image","twitter_creator":"@ASKRegASK","twitter_site":"@ASKRegASK","twitter_misc":{"Written by":"Benoit Trouwaert","Est. reading time":"3 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/regask.com\/australia-compliance-priorities-2022\/#article","isPartOf":{"@id":"https:\/\/regask.com\/australia-compliance-priorities-2022\/"},"author":{"name":"Benoit Trouwaert","@id":"https:\/\/regask.com\/#\/schema\/person\/c1d261e8dcf7b1c30b2c4f2c119df42d"},"headline":"Australia: Import, Advertising and Supply Compliance Pr…","datePublished":"2022-08-02T01:30:47+00:00","dateModified":"2024-10-24T16:45:40+00:00","mainEntityOfPage":{"@id":"https:\/\/regask.com\/australia-compliance-priorities-2022\/"},"wordCount":444,"publisher":{"@id":"https:\/\/regask.com\/#organization"},"image":{"@id":"https:\/\/regask.com\/australia-compliance-priorities-2022\/#primaryimage"},"thumbnailUrl":"https:\/\/regask.com\/wp-content\/uploads\/2021\/04\/pharma-pills.png","keywords":["Latest Insights"],"articleSection":["Australia","Pharma and Biotech"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/regask.com\/australia-compliance-priorities-2022\/","url":"https:\/\/regask.com\/australia-compliance-priorities-2022\/","name":"Australia: prioridades de cumplimiento de las normas de importaci\u00f3n, publicidad y suministro para 2022 | RegASK","isPartOf":{"@id":"https:\/\/regask.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/regask.com\/australia-compliance-priorities-2022\/#primaryimage"},"image":{"@id":"https:\/\/regask.com\/australia-compliance-priorities-2022\/#primaryimage"},"thumbnailUrl":"https:\/\/regask.com\/wp-content\/uploads\/2021\/04\/pharma-pills.png","datePublished":"2022-08-02T01:30:47+00:00","dateModified":"2024-10-24T16:45:40+00:00","description":"La TGA de Australia ha publicado una lista de prioridades de cumplimiento en materia de importaci\u00f3n, publicidad y suministro desde el 1 de julio de 2022 hasta el 30 de junio de 2023.","inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/regask.com\/australia-compliance-priorities-2022\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/regask.com\/australia-compliance-priorities-2022\/#primaryimage","url":"https:\/\/regask.com\/wp-content\/uploads\/2021\/04\/pharma-pills.png","contentUrl":"https:\/\/regask.com\/wp-content\/uploads\/2021\/04\/pharma-pills.png","width":689,"height":626,"caption":"Medication tablets"},{"@type":"WebSite","@id":"https:\/\/regask.com\/#website","url":"https:\/\/regask.com\/","name":"RegASK","description":"Habilitando decisiones regulatorias m\u00e1s inteligentes","publisher":{"@id":"https:\/\/regask.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/regask.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/regask.com\/#organization","name":"RegASK","url":"https:\/\/regask.com\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/regask.com\/#\/schema\/logo\/image\/","url":"https:\/\/regask.com\/wp-content\/uploads\/2024\/10\/RegASK-Logo-Dark-Round.png","contentUrl":"https:\/\/regask.com\/wp-content\/uploads\/2024\/10\/RegASK-Logo-Dark-Round.png","width":401,"height":401,"caption":"RegASK"},"image":{"@id":"https:\/\/regask.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/RegASKRegulatoryAffairs\/","https:\/\/x.com\/ASKRegASK","https:\/\/www.linkedin.com\/company\/RegASK\/","https:\/\/www.youtube.com\/playlist?list=PL6yPC6gFqelkHbOeyUVKjtHOZXZ2LQbJd"]},{"@type":"Person","@id":"https:\/\/regask.com\/#\/schema\/person\/c1d261e8dcf7b1c30b2c4f2c119df42d","name":"Benoit Trouwaert"}]}},"_links":{"self":[{"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/posts\/3764","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/users\/39"}],"replies":[{"embeddable":true,"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/comments?post=3764"}],"version-history":[{"count":0,"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/posts\/3764\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/media\/2487"}],"wp:attachment":[{"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/media?parent=3764"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/categories?post=3764"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/tags?post=3764"}],"curies":[{"name":"Gracias","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}